chevron_leftBack
As of 23 June 2026, HARBIN GLORIA PHARMACEUTICALS Co., LTD. has a market cap of $1.16B USD, ranking #9896 globally and #2739 in China.
It ranks #869 in the Healthcare sector, and #329 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.16BUSD
7.85B CNY
Enterprise Value
$1.03BUSD
6.94B CNY
Revenue (TTM)
$313.41MUSD
2.12B CNY
Net Income (TTM)
$60.75MUSD
411.58M CNY
Profit Margin
19%
PE Ratio
19.1
PS Ratio
3.7
PB Ratio
3.3
EV/EBITDA
22.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Leifeng Guo
open_in_new
Employees
2,703
Founded
2000
Website
gloria.cc
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.8% | -3.6% | 4.5% | 1.1% | 5.4% | 42% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002437
哈尔滨誉衡药业股份有限公司 Class A
ISIN: CNE100000QG8
Shares Out.:
Shares Outstanding:
2.062B1
Shares Float:
1.599B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3.52 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About HARBIN GLORIA PHARMACEUTICALS Co., LTD.
HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.86B
5K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.65B
4K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.51B
2K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.79B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.52B
1K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.0B
1K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
66K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
47K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
31K%
|
97.4
|
|
SIX: RO
|
$316.71B
27K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$285.49B
25K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
24K%
|
15.1
|
chevron_leftBack